Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 3Dermatologic 2Endocrine 1

Conditions

Pituitary Neoplasms 1

Interventions

Surveys and Questionnaires 8Blood Specimen Collection 7lutetium Lu 177 dotatate 6Surgical Procedures, Operative 6Magnetic Resonance Spectroscopy 6Adrenalectomy 5Observation 4Transurethral Resection of Prostate 3Thyroidectomy 3Positron-Emission Tomography 3Lymph Node Excision 3Data Collection 3telotristat ethyl 2surufatinib 2gallium Ga 68 dotatate 2Somatostatin 2Radionuclide Imaging 2Radiofrequency Ablation 2Everolimus 2Drug Therapy 2Biopsy 2somapacitan 1methyl hydroxyethyl cellulose 1lanreotide 1fluorodopa F 18 1exemestane 1delta 24-sterol reductase 1copper dotatate CU-64 1Whole Body Imaging 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Aminolevulinic Acid × Endocrine × Clear all
NCT04390802 2021-02-24

A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

Massachusetts General Hospital

Unknown
40 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡